Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR sell supont

Start price
€70.99
31.12.20 / 50%
Target price
€50.00
31.12.21
Performance (%)
216.81%
End price
€224.90
01.01.22
Summary
This prediction ended on 01.01.22 with a price of €224.90. The SELL prediction by supont for BioNTech SE ADR was trending in the completely wrong direction and closed with a performance of 216.81%. supont has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® -1.785% -1.250% 11.664% 12.714%
iShares Nasdaq 100 -2.154% 0.300% 37.531% 41.653%
iShares Nikkei 225® -4.028% -3.746% 17.142% 0.393%
iShares S&P 500 -1.969% 0.307% 25.617% 40.084%

According to supont what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Cons
Risky Investment
Below average Marketposition
Little known brand
Outdated or very high risk business model

Comments by supont for this prediction

In the thread Biontech SE diskutieren
Prediction Sell
Perf. (%) 216.81%
Target price 50.000
Change
Ends at

Sell mit Kursziel 50,0

In the thread Trading Biontech SE
Prediction Sell
Perf. (%) 216.81%
Target price 50.000
Change
Ends at 31.12.21

Die von supont gewählte maximale Laufzeit wurde überschritten